146 related articles for article (PubMed ID: 30543413)
1. Cysteine-Directed Bioconjugation of a Platinum(II)-Acridine Anticancer Agent.
Yao X; Tracy CM; Bierbach U
Inorg Chem; 2019 Jan; 58(1):43-46. PubMed ID: 30543413
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a Platinum-Acridine Anticancer Agent and Its Liposomal Formulation in an in vivo Model of Lung Adenocarcinoma.
Ding S; Hackett CL; Liu F; Hackett RG; Bierbach U
ChemMedChem; 2021 Jan; 16(2):412-419. PubMed ID: 32975041
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological activity of a novel non-cisplatin-type platinum-acridine pharmacophore.
Martins ET; Baruah H; Kramarczyk J; Saluta G; Day CS; Kucera GL; Bierbach U
J Med Chem; 2001 Dec; 44(25):4492-6. PubMed ID: 11728195
[TBL] [Abstract][Full Text] [Related]
4. PT-ACRAMTU, a platinum-acridine anticancer agent, lengthens and aggregates, but does not stiffen or soften DNA.
Dutta S; Snyder MJ; Rosile D; Binz KL; Roll EH; Suryadi J; Bierbach U; Guthold M
Cell Biochem Biophys; 2013; 67(3):1103-13. PubMed ID: 23636685
[TBL] [Abstract][Full Text] [Related]
5. Comparative chemogenomics to examine the mechanism of action of dna-targeted platinum-acridine anticancer agents.
Cheung-Ong K; Song KT; Ma Z; Shabtai D; Lee AY; Gallo D; Heisler LE; Brown GW; Bierbach U; Giaever G; Nislow C
ACS Chem Biol; 2012 Nov; 7(11):1892-901. PubMed ID: 22928710
[TBL] [Abstract][Full Text] [Related]
6. Redesigning the DNA-targeted chromophore in platinum-acridine anticancer agents: a structure-activity relationship study.
Pickard AJ; Liu F; Bartenstein TF; Haines LG; Levine KE; Kucera GL; Bierbach U
Chemistry; 2014 Dec; 20(49):16174-87. PubMed ID: 25302716
[TBL] [Abstract][Full Text] [Related]
7. Large-Pore Functionalized Mesoporous Silica Nanoparticles as Drug Delivery Vector for a Highly Cytotoxic Hybrid Platinum-Acridine Anticancer Agent.
Zheng Y; Fahrenholtz CD; Hackett CL; Ding S; Day CS; Dhall R; Marrs GS; Gross MD; Singh R; Bierbach U
Chemistry; 2017 Mar; 23(14):3386-3397. PubMed ID: 28122141
[TBL] [Abstract][Full Text] [Related]
8. Bis(acridinylthiourea)platinum(II) complexes: synthesis, DNA affinity, and biological activity in glioblastoma cells.
Augustus TM; Anderson J; Hess SM; Bierbach U
Bioorg Med Chem Lett; 2003 Mar; 13(5):855-8. PubMed ID: 12617907
[TBL] [Abstract][Full Text] [Related]
9. A membrane transporter determines the spectrum of activity of a potent platinum-acridine hybrid anticancer agent.
Yao X; Watkins NH; Brown-Harding H; Bierbach U
Sci Rep; 2020 Sep; 10(1):15201. PubMed ID: 32939009
[TBL] [Abstract][Full Text] [Related]
10. Development of Prodrug-Payloads for Targeted Therapeutic Applications of Platinum-Acridine Anticancer Agents.
Mancera-Ortiz IY; Chen J; Slade TA; Yao X; Zhang S; Day CS; Bierbach U
Bioconjug Chem; 2023 Oct; 34(10):1873-1881. PubMed ID: 37813818
[TBL] [Abstract][Full Text] [Related]
11. Developing an anticancer copper(II) pro-drug based on the nature of cancer cell and human serum albumin carrier IIA subdomain: mouse model of breast cancer.
Gou Y; Zhang Y; Qi J; Chen S; Zhou Z; Wu X; Liang H; Yang F
Oncotarget; 2016 Oct; 7(41):67004-67019. PubMed ID: 27564255
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, cytotoxicity and structure-activity relationships between ester and amide functionalities in novel acridine-based platinum(II) complexes.
Bouyer F; Moretto J; Pertuit D; Szollosi A; Lacaille-Dubois MA; Blache Y; Chauffert B; Desbois N
J Inorg Biochem; 2012 May; 110():51-7. PubMed ID: 22459174
[TBL] [Abstract][Full Text] [Related]
13. Using a build-and-click approach for producing structural and functional diversity in DNA-targeted hybrid anticancer agents.
Ding S; Qiao X; Kucera GL; Bierbach U
J Med Chem; 2012 Nov; 55(22):10198-203. PubMed ID: 23074987
[TBL] [Abstract][Full Text] [Related]
14. A non-cross-linking platinum-acridine agent with potent activity in non-small-cell lung cancer.
Ma Z; Choudhury JR; Wright MW; Day CS; Saluta G; Kucera GL; Bierbach U
J Med Chem; 2008 Dec; 51(23):7574-80. PubMed ID: 19012390
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological activity, and DNA-damage profile of platinum-threading intercalator conjugates designed to target adenine.
Guddneppanavar R; Saluta G; Kucera GL; Bierbach U
J Med Chem; 2006 Jun; 49(11):3204-14. PubMed ID: 16722638
[TBL] [Abstract][Full Text] [Related]
16. DNA-directed alkylating agents. 5. Acridinecarboxamide derivatives of (1,2-diaminoethane)dichloroplatinum(II).
Lee HH; Palmer BD; Baguley BC; Chin M; McFadyen WD; Wickham G; Thorsbourne-Palmer D; Wakelin LP; Denny WA
J Med Chem; 1992 Aug; 35(16):2983-7. PubMed ID: 1501223
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of non-cisplatin type DNA-targeted platinum anticancer agents: DNA interactions of novel acridinylthioureas and their platinum conjugates.
Baruah H; Rector CL; Monnier SM; Bierbach U
Biochem Pharmacol; 2002 Jul; 64(2):191-200. PubMed ID: 12123739
[TBL] [Abstract][Full Text] [Related]
18. A Nanobody-Conjugated DNA Nanoplatform for Targeted Platinum-Drug Delivery.
Wu T; Liu J; Liu M; Liu S; Zhao S; Tian R; Wei D; Liu Y; Zhao Y; Xiao H; Ding B
Angew Chem Int Ed Engl; 2019 Oct; 58(40):14224-14228. PubMed ID: 31389144
[TBL] [Abstract][Full Text] [Related]
19. A platinum Chugaev carbene complex as a potent anticancer agent.
Alves G; Morel L; El-Ghozzi M; Avignant D; Legeret B; Nauton L; Cisnetti F; Gautier A
Chem Commun (Camb); 2011 Jul; 47(27):7830-2. PubMed ID: 21647511
[TBL] [Abstract][Full Text] [Related]
20. Palladium(ii) and platinum(ii) saccharinate complexes with bis(diphenylphosphino)methane/ethane: synthesis, S-phase arrest and ROS-mediated apoptosis in human colon cancer cells.
Icsel C; Yilmaz VT; Aygun M; Cevatemre B; Alper P; Ulukaya E
Dalton Trans; 2018 Aug; 47(33):11397-11410. PubMed ID: 30062356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
